Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)

David M. Wright; Evgenia Konstantakopoulou; Giovanni Montesano; Neil Nathwani; Anurag Garg; David F. Garway‐Heath; David P. Crabb; Gus Gazzard; Mariam Adeleke; Gareth Ambler; Keith Barton; Rupert Bourne; David C. Broadway; Catey Bunce; Marta Buszewicz; David P. Crabb; Amanda Davis; Anurag Garg; David F. Garway‐Heath; Gus Gazzard; Daniel Hornan; Rachael Hunter; Hari Jayaram; Yuzhen Jiang; Evgenia Konstantakopoulou; Sheng Yang Lim; Joanna Liput; T D Manners; Giovanni Montesano; Stephen Morris; Neil Nathwani; Giovanni Ometto; Gary S. Rubin; Nicholas G. Strouthidis; Victoria Vickerstaff; Sarah E. Wilson; Richard Wormald; David M. Wright; Haogang Zhu

doi:10.1016/j.ophtha.2020.03.029

Abstract

A slightly larger proportion of ocular hypertensive and glaucoma patients treated first with medical therapy underwent rapid VF progression compared with those treated first with SLT.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wright et al. (2020) studied this question.

synapsesocial.com/papers/69d7329f0420a49c9848f3d4 https://doi.org/10.1016/j.ophtha.2020.03.029

View Full Paper

Ask AI

Bookmark

Share

Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)

Abstract

Discussion

Cite This Study

Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)

Abstract

Discussion

Cite This Study

Keep reading

Keep reading